These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15178743)

  • 1. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
    Askew EB; Minges JT; Hnat AT; Wilson EM
    Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
    He B; Wilson EM
    Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain.
    van de Wijngaart DJ; van Royen ME; Hersmus R; Pike AC; Houtsmuller AB; Jenster G; Trapman J; Dubbink HJ
    J Biol Chem; 2006 Jul; 281(28):19407-16. PubMed ID: 16690616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.
    Bai S; He B; Wilson EM
    Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.
    Estébanez-Perpiñá E; Moore JM; Mar E; Delgado-Rodrigues E; Nguyen P; Baxter JD; Buehrer BM; Webb P; Fletterick RJ; Guy RK
    J Biol Chem; 2005 Mar; 280(9):8060-8. PubMed ID: 15563469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
    Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
    He B; Gampe RT; Kole AJ; Hnat AT; Stanley TB; An G; Stewart EL; Kalman RI; Minges JT; Wilson EM
    Mol Cell; 2004 Nov; 16(3):425-38. PubMed ID: 15525515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FXXLF motif mediates androgen receptor-specific interactions with coregulators.
    He B; Minges JT; Lee LW; Wilson EM
    J Biol Chem; 2002 Mar; 277(12):10226-35. PubMed ID: 11779876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.
    Askew EB; Gampe RT; Stanley TB; Faggart JL; Wilson EM
    J Biol Chem; 2007 Aug; 282(35):25801-16. PubMed ID: 17591767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
    Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
    Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of coregulator-induced conformational perturbations in androgen receptor ligand binding domain.
    Zakharov MN; Pillai BK; Bhasin S; Ulloor J; Istomin AY; Guo C; Godzik A; Kumar R; Jasuja R
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):1-8. PubMed ID: 21605623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.
    van de Wijngaart DJ; Dubbink HJ; Molier M; de Vos C; Trapman J; Jenster G
    Mol Endocrinol; 2009 Nov; 23(11):1776-86. PubMed ID: 19762545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
    He B; Kemppainen JA; Wilson EM
    J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
    Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
    Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
    Jehle K; Cato L; Neeb A; Muhle-Goll C; Jung N; Smith EW; Buzon V; Carbó LR; Estébanez-Perpiñá E; Schmitz K; Fruk L; Luy B; Chen Y; Cox MB; Bräse S; Brown M; Cato AC
    J Biol Chem; 2014 Mar; 289(13):8839-51. PubMed ID: 24523409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.